TuHURA Biosciences Inc. (HURA)
NASDAQ: HURA
· Real-Time Price · USD
3.06
0.30 (10.87%)
At close: Aug 15, 2025, 3:59 PM
3.00
-2.12%
After-hours: Aug 15, 2025, 07:58 PM EDT
TuHURA Biosciences Cash Flow Statement
Financials in USD. Fiscal
year is
undefined.
| Fiscal Year | Q4 2024 | Q3 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Dec 31, 2024 | Sep 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -14.02M | -8.03M | -9.2M | -23.07M | -25.5M | -30.09M | -32.2M | -19.39M | -21.9M | -24.04M | -25.23M | -24.75M | -38.3M | -35.39M |
Depreciation & Amortization | 69.64K | 52K | 38K | 90.45K | 90.45K | 105.45K | 105.45K | 60K | 60K | 60K | 60K | 46K | 32K | 18.55K |
Stock-Based Compensation | 435.6K | 435.6K | 334.6K | 169.65K | 169.65K | 169.65K | 169.65K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Working Capital | -678.75K | -404K | -277K | -722.95K | -707.95K | -2.6M | -2.84M | -2.5M | -2.54M | -368K | -123K | -2.41M | -2.59M | -2.75M |
Other Non-Cash Items | 2.63M | 1.38M | 2.75M | 17.78M | 19.08M | 19.5M | 18.1M | 2.73M | 2.06M | 2.79M | 4.82M | 6.32M | 22.06M | 21.14M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 447.86K | -1.68M | -1.38M | -1.82M | -737.95K | -2.96M | -2.93M | -2.03M | -1.76M | 1.32M | 849K | -1.44M | -2.65M | -2.52M |
Operating Cash Flow | -10.44M | -7.84M | -7.46M | -6.86M | -6.9M | -13.27M | -16.75M | -18.63M | -21.54M | -19.86M | -19.5M | -19.82M | -18.86M | -16.75M |
Capital Expenditures | -41.4K | -20K | -20K | -20K | n/a | -232K | -232K | -232K | -232K | n/a | -8K | -8K | -8K | -8K |
Cash Acquisitions | n/a | n/a | n/a | -1.2M | -1.2M | -1.2M | -1.2M | n/a | n/a | n/a | n/a | 3K | 972K | 972K |
Purchase of Investments | -802.13K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | -843.54K | -20K | -20K | -1.22M | -1.2M | -1.43M | -1.43M | -232K | -232K | n/a | -8K | -5K | 964K | 964K |
Debt Repayment | 32.35M | 32.36M | 4.9M | n/a | n/a | n/a | n/a | n/a | n/a | -500K | -500K | -500K | n/a | 500K |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | -4K | -4K | -6K | -4K | -4K | -6K | -6K | -8K | -8K | -8K | -8K | -8K | -8K | -8.09K |
Other Financial Acitivies | -4.7M | -270.3K | -313.3K | -43K | -43K | -43K | n/a | n/a | n/a | -30K | -30K | -30K | -30K | -25K |
Financial Cash Flow | 3.69M | 7.21M | 7.21M | 2.58M | -52K | 1.85M | 9.79M | 9.62M | 23.54M | 21.14M | 16.41M | 16.57M | 26.04M | 26.53M |
Net Cash Flow | -1.09M | -1.09M | 796.46K | -4.43M | -4.43M | -4.43M | -4.43M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Free Cash Flow | -10.48M | -7.86M | -7.48M | -6.88M | -6.9M | -13.5M | -16.99M | -18.86M | -21.77M | -19.86M | -19.5M | -19.83M | -18.87M | -16.76M |